“Having caused around five million deaths worldwide as of October 2021, the Covid-19 pandemic and an IP waiver proposal on Covid-19 related medical products before the WTO have been issues of world attention. In particular, the discussion has gained momentum around the development of cutting-edge vaccines that utilize existing patented advances, such as those mRNA versions produced by Moderna and Pfizer/BioNTech, and their complex production and global distribution processes …” (more)
[Cristian Camilo Polo Caquimbo, Maastricht University, 12 November]
First posted 2021-11-13 14:00:39
Leave a Reply